Poxel News and Activities

Presence

Poxel is a pharmaceutical company that develops treatments for metabolic and rare diseases. Its drug candidates and research programs support patients, healthcare providers, and pharmaceutical partners.

Poxel products and services overview:

  • Metabolic disease drugs
  • Rare disease drugs
  • Drug development
  • Clinical research

Revenue: ~$4 million

Employees: 35

Headquarters: Lyon, France


Poxel is one of the...

Poxel is a company listed under the stock ticker POXEL (FR).

Executives

View the org chart displaying its 9 main executives

Most searched biographies at Poxel
Popular executive movements at Poxel
  • Yves Decadt has joined the company as Director  (posted on November 3 2025).

Create your alert
to follow the executive moves at Poxel.

Pharmaceuticals

Poxel has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals
Popular contacts in Pharmaceuticals

Learn more about the Pharmaceuticals industry

News

Press releases by Poxel
Social media about Poxel

Get in Touch

Call Poxel at +33 43...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board